Here Is When You Will Get Vaccinated - GoLocal Daily RI Vaccination Update
GoLocalProv News Team
Here Is When You Will Get Vaccinated - GoLocal Daily RI Vaccination Update
GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST
1. Here Is When You Are Scheduled to Be Vaccinated According to the Raimondo Administration
After months of delay, and repeatedly refusing to disclose the most basic facts about vaccinations, the Rhode Island Department of Health (RIDOH) has finally released a schedule as to when Rhode Islanders are likely to be vaccinated
RIDOH took months to release the data. The agency has been plagued by errors and missteps.
In December, a GoLocal investigation unveiled the agency was producing incorrect information, an outdated plan, and that thousands of doses of vaccines sitting on shelves. RIDOH officials can’t identify how many Rhode Islanders need to be vaccinated. More disturbing is that the state’s definition of how many need to be vaccinated to achieve “herd immunity” is significantly lower than President-elect Joe Biden’s Chief Medical Advisor Anthony Fauci's number.
The state still does not have a centralized registration system for Rhode Islanders to be notified and scheduled.
2. RI Now Has Utilized 52% of Its Vaccine
RIDOH officials continue to struggle to get Rhode Islanders vaccinated.
According to the CDC and updated on Saturday, RI has now:
Received 157,525 doses
Administered 83,607 doses (more than 4,000 administered in past 24-hours)
Of the vaccine doses received, RI has utilized 53%
Updated 1/30/2021
3. Johnson & Johnson 66% Effective
Johnson & Johnson is expected to seek FDA Emergency Use Authorization next week.
Johnson & Johnson announced Friday that its single-shot coronavirus vaccine was 66% effective in protecting against moderate to severe COVID-19 disease in Phase 3 trials, which was comprised of nearly 44,000 participants across eight countries.
“Johnson & Johnson embarked on the global effort to combat the COVID-19 pandemic a year ago, and has brought the full force of our capabilities, as well as tremendous public-private partnerships, to enable the development of a single-shot vaccine. Our goal all along has been to create a simple, effective solution for the largest number of people possible, and to have maximum impact to help end the pandemic,” said Alex Gorsky, Chairman, Board of Directors and Chief Executive Officer, Johnson & Johnson, in the company's release.
"The vaccine was 72% effective in the U.S., but only 57% effective in South Africa, where a more contagious variant has been spreading. It prevented 85% of severe infections and 100% of hospitalizations and deaths, according to the company."
This week, the United States Centers for Disease Control and Prevention announced Thursday that it is aware that the first US documented cases of the B 1.351 variant of SARS-CoV-2, which was first detected in South Africa, have been identified in South Carolina.
"The J&J vaccine turns in a fantastic result. We now have 3 highly effective vaccines. This vaccine showed sustained (and increasing!) immune protection over time, perhaps from a robust early induction of memory immune cells (CD4 and CD8)," tweeted former FDA commissioner Scott Gottlieb.
4. Coming on Sunday on GoLocal - a comprehensive review of all of the vaccines and what is known about their efficacy on the new and highly infectious variants.